Antares Pharma

Antares Pharma, Inc., (NASDAQ: ATRS) was trading -48.17% away from its yearly high level, during the last trading session. The

Antares Pharma, Inc., (NASDAQ: ATRS) was trading -45.48% away from its yearly high level, during the last trading session. The

Antares Pharma, Inc., (NASDAQ: ATRS) was trading -48.90% away from its yearly high level, during the last trading session. The

Antares Pharma, Inc., (NASDAQ: ATRS) was trading -48.78% away from its yearly high level, during the last trading session. The

Antares Pharma, Inc., (NASDAQ: ATRS) was trading -43.28% away from its yearly high level, during the last trading session. The

Antares Pharma, Inc., (NASDAQ: ATRS) was trading -8.80% away from its yearly high level, during the last trading session. The

Antares Pharma, Inc., (NASDAQ: ATRS) was trading -3.67% away from its yearly high level, during the last trading session. The

Antares Pharma, Inc., (NASDAQ: ATRS) was trading -3.18% away from its yearly high level, during the last trading session. The

Antares Pharma, Inc., (NASDAQ: ATRS) was trading -5.54% away from its yearly high level, during the last trading session. The

Antares Pharma, Inc., (NASDAQ: ATRS) was trading -4.07% away from its yearly high level, during the last trading session. The